When a cat gets a stuffy nose, it’s easy to assume a kitty cold is the culprit…especially if they’re also sneezing and ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

Dupilumab was effective for patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) at 52 weeks.

Nasal sinusitis, commonly called a sinus infection, is a condition characterised by inflammation or swelling of the tissue ...

Patients with CRSwNP have a high burden of SCS use and associated health care costs, especially when they have comorbid asthma.

A new study published in the Ear, Nose and Throat Journal found that the severity of chronic rhinosinusitis with nasal ...

Celltrion today announced that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is approved ...

based on an analysis of (1) the occurrence of polyps and of allergy, (2) the anatomy and histology of nasal polyps, (3) the inflammation in nasal polyps, (4) the occurrence of positive allergy tests ...

Treatment will depend on the cause, but may include inhaled corticosteroid drugs ... South Med J. 2013;106(11):642-648. Cedars Sinai. Nasal polyps. ENT Health. Deviated septum. Stanford Medicine.

A research team led by Professor Lee Kun-hee at Gangdong Kyunghee University Hospital has announced new evaluation criteria ...